1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES
申请人:G.D. Searle LLC
公开号:EP1155007A2
公开(公告)日:2001-11-21
[EN] NOVEL 1,2-BENZOTHIAZEPINES HAVING ACTIVITY AS INHIBITORS OF ILEAL BILE ACID TRANSPORT AND TAUROCHOLATE UPTAKE<br/>[FR] NOUVELLES BENZOTHIAZEPINES-1,2 PRESENTANT UNE ACTIVITE D'INHIBITION DE TRANSPORT D'ACIDE BILIAIRE ILEAL ET D'ABSORPTION DE TAUROCHOLATE
申请人:SEARLE & CO
公开号:WO2000047568A2
公开(公告)日:2000-08-17
Novel 1,1-dioxido-1,2-benzothiazepines, derivatives and analogs thereof, pharmaceutical compositions containing them, and their use in medicine, particularly in the prophylaxis and/or treatment of hyperlipidemic diseases, conditions and/or disorders, such as those associated with atherosclerosis and/or hypercholesterolemia.
A novel class of apical sodium co-dependent bile acid transporter inhibitors: The 1,2-Benzothiazepines
作者:Michael B. Tollefson、Stephen A. Kolodziej、Theresa R. Fletcher、William F. Vernier、Judith A. Beaudry、Bradley T. Keller、David B. Reitz
DOI:10.1016/j.bmcl.2003.08.004
日期:2003.11
2-benzothiazepin-4-ol 1,1-dioxides were prepared and were found to inhibit the apical sodium co-dependent bile acid transporter (ASBT) for the potential treatment for hyperlipidemia. Several 1,2-benzothiazepines exhibited low nanomolar in vitro activity. The synthesis and initial in vitro potency data is presented for this novelclass of compounds.